-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Cytokinetics Inc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2024.
- Cytokinetics Inc Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $15M, a 97.9% increase year-over-year.
- Cytokinetics Inc Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $51.5M, a 86.5% increase year-over-year.
- Cytokinetics Inc annual Nonoperating Income (Expense) for 2024 was $51.5M, a 86.5% increase from 2023.
- Cytokinetics Inc annual Nonoperating Income (Expense) for 2023 was $27.6M, a 144% increase from 2022.
- Cytokinetics Inc annual Nonoperating Income (Expense) for 2022 was $11.3M, a 3327% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)